Literature DB >> 9481013

Risky business: challenges in vaccine risk communication.

L K Ball1, G Evans, A Bostrom.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9481013     DOI: 10.1542/peds.101.3.453

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  32 in total

1.  Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies.

Authors:  Priya Bahri
Journal:  Drug Saf       Date:  2010-12-01       Impact factor: 5.606

2.  The role of media and the Internet on vaccine adverse event reporting: a case study of human papillomavirus vaccination.

Authors:  Jan M Eberth; Kimberly N Kline; David A Moskowitz; Jane R Montealegre; Michael E Scheurer
Journal:  J Adolesc Health       Date:  2013-11-17       Impact factor: 5.012

Review 3.  Epidemiology of vaccine hesitancy in the United States.

Authors:  Mariam Siddiqui; Daniel A Salmon; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2013-11-18       Impact factor: 3.452

4.  Exploring California's new law eliminating personal belief exemptions to childhood vaccines and vaccine decision-making among homeschooling mothers in California.

Authors:  Pamela McDonald; Rupali J Limaye; Saad B Omer; Alison M Buttenheim; Salini Mohanty; Nicola P Klein; Daniel A Salmon
Journal:  Vaccine       Date:  2019-01-06       Impact factor: 3.641

5.  Cognitive Bias in Clinicians' Communication about Human Papillomavirus Vaccination.

Authors:  Caitlin E Hansen; Anna North; Linda M Niccolai
Journal:  Health Commun       Date:  2019-01-24

6.  Pediatric Care Provider Density and Personal Belief Exemptions From Vaccine Requirements in California Kindergartens.

Authors:  Edward T Walker; Christopher M Rea
Journal:  Am J Public Health       Date:  2016-05-19       Impact factor: 9.308

7.  Assessing the State of Vaccine Confidence in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015 [corrected].

Authors: 
Journal:  Public Health Rep       Date:  2015 Nov-Dec       Impact factor: 2.792

8.  Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service.

Authors:  M Gold; H Goodwin; S Botham; M Burgess; M Nash; A Kempe
Journal:  Arch Dis Child       Date:  2000-08       Impact factor: 3.791

9.  How can we communicate about vaccines with adolescents and their parents?

Authors:  Andrea L Benin; Ann C Wu; Eric S Holmboe; Eugene D Shapiro; Walter Anyan
Journal:  Clin Pediatr (Phila)       Date:  2010-01-28       Impact factor: 1.168

10.  Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial.

Authors:  Maria I Danila; Ryan C Outman; Elizabeth J Rahn; Amy S Mudano; David T Redden; Peng Li; Jeroan J Allison; Fred A Anderson; Allison Wyman; Susan L Greenspan; Andrea Z LaCroix; Jeri W Nieves; Stuart L Silverman; Ethel S Siris; Nelson B Watts; Michael J Miller; Jeffrey R Curtis; Amy H Warriner; Nicole C Wright; Kenneth G Saag
Journal:  J Bone Miner Res       Date:  2018-02-26       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.